CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 165 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 4.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $378,000 | -72.9% | 15,000 | -70.0% | 0.01% | -72.0% |
| Q1 2015 | $1,394,000 | +155.8% | 50,000 | +66.7% | 0.02% | +150.0% |
| Q4 2014 | $545,000 | +12.6% | 30,000 | +50.0% | 0.01% | +11.1% |
| Q4 2013 | $484,000 | -45.4% | 20,000 | -20.0% | 0.01% | -47.1% |
| Q3 2013 | $886,000 | +89.3% | 25,000 | -16.7% | 0.02% | +88.9% |
| Q2 2013 | $468,000 | – | 30,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 844,981 | $15,421,000 | 7.11% |
| DOHENY ASSET MANAGEMENT /CA | 195,345 | $3,565,000 | 1.70% |
| First Light Asset Management, LLC | 153,617 | $2,804,000 | 1.59% |
| Rhenman & Partners Asset Management AB | 175,000 | $3,194,000 | 0.93% |
| Iguana Healthcare Management, LLC | 100,000 | $1,825,000 | 0.88% |
| Eventide Asset Management | 288,700 | $5,269,000 | 0.58% |
| Bedell Frazier Investment Counselling, LLC | 60,820 | $1,110,000 | 0.54% |
| STONERIDGE INVESTMENT PARTNERS LLC | 214,327 | $3,911,000 | 0.52% |
| Fernwood Investment Management, LLC | 31,350 | $572,000 | 0.49% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 168,560 | $3,076,000 | 0.37% |